最新报道:Profusa's stock surged 21.82% following its announcement to adopt a Bitcoin treasury strategy, mirroring moves by companies like MicroStrategy. The biotech firm plans to allocate a portion of its cash reserves into Bitcoin, citing its potential as a hedge against inflation and long-term store of value. CEO Ben Hwang emphasized the strategic shift aims to maximize shareholder value amid macroeconomic uncertainties. The decision reflects growing corporate interest in cryptocurrency as an alternative asset class, despite market volatility. Analysts note the trend could gain traction among cash-rich tech and biotech firms seeking diversification.